Synopsis: The Insurance stock moved up nearly 1.2% after board approval for an insurance amalgamation involving a 19.02% Axis stake. The life insurer serves 50+ million customers, boasts a 99.70% claim settlement ratio, manages ₹1.7 lakh crore in assets, and operates...
Synopsis:- The shipbuilding PSU posted strong Q3FY26 results with revenue up 49% and profit rising 74% year-on-year. EBITDA jumped 59%, reflecting operational strength. The stock reacted positively, gaining 5%, alongside the announcement of a ₹7.15 interim dividend,...
Synopsis:- Axis Direct maintained a ‘Buy’ call with a ₹2,200 target, implying ~43% upside. Volume recovery is expected as 125,000 tonnes of new capacity come online by Q4FY26. Plastic volumes jumped 55% QoQ, margins improved to 12%, and management targets 25% volume...
Synopsis:- The stock jumped nearly 10% after strong Q3FY26 results, supported by an order book of ₹73,015 crore. EBITDA rose 27.3% with margins improving to 29.7%. Heavy volumes of ~67.5 million shares and an RSI near 72 reflected strong buying interest, while...
Synopsis: Shares rose over 3% after securing a 248.85 MW wind order, strengthening its role in green steel. The order book stands at ~6.2 GW, with record quarterly deliveries of 565 MW and a strong H2 pipeline of 1,865 MW. Management targets 25% market share in FY26,...
Synopsis:- Several large-cap stocks were in focus after Goldman Sachs executed block deals, buying over 5.13 million, 2.17 million, and 2.56 million shares across counters. The transactions, worth over ₹1,000 crore, were matched by Morgan Stanley sales, indicating...
Synopsis: Shares of two FMCG snack players moved higher after Q3FY26 results. Revenue rose to ₹790 crore and ₹401 crore, while net profit surged to ₹62 crore and ₹15 crore. Strong segment growth, EBITDA up nearly 96%, expanding distribution, and capacity ramp-ups...
Synopsis:- The stock gained up to 5% after strong Q3FY26 results, with revenue up 112% YoY to Rs 344 crore and profit rising 33% to Rs 57 crore. Pre-sales grew 16% YoY to Rs 734 crore, margins remained healthy, and low leverage of 0.07x supported a positive...
Synopsis:- The stock jumped up to 6% after receiving in-principle approval to migrate from the SME platform to the main board. The move is expected to improve liquidity and visibility, supported by rising operating profit, stable 13% margins, over 5.5 GW capacity, and...
Synopsis:- The stock plunged nearly 20% after Q3FY26 losses widened and delayed semaglutide approvals in Canada hit volumes. Revenue fell 26% YoY to ₹290 crore, while margins dropped to 6%. Despite near-term pressure, FY28 guidance remains intact with ~$500 million...
